VG-712

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameVG-712
Drug Alias NameA-dmDT390-bisFv(UCHT1) Fusion Protein (VG712)VG712VG-712
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-CD3
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsMycosis Fungoides
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVirogen Biotechnology Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMycosis Fungoides
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A